DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, today announced the launch of their latest CGM system, Dexcom ONE+. The system is available today in Spain, Belgium, and Poland and launches next week in the Netherlands. In some countries Dexcom ONE+ replaces the previous generation Dexcom ONE sensor. Dexcom ONE+ uses Dexcom’s most accurate sensor design. Dexcom also incorporated feedback from both end users and healthcare professionals when building Dexcom ONE+, ensuring an easy-to-use, highly effective, CGM experience for people treating their Type 1 or Type 2 diabetes with insulin.
For people managing diabetes using fingerpricks and regularly injecting insulin, their lives can feel overwhelmed by diabetes. Dexcom ONE+ was developed to take away some of this burden, it’s easy to get started with and is designed to be easy to live with, even for those with no experience of using a CGM system. Like all Dexcom CGM, Dexcom ONE+ gives a clear picture of what glucose levels are doing in real-time, without painful finger pricks, therefore making it easier for people to achieve lasting results. Importantly, for loved ones, Dexcom ONE+ also allows a user to easily share their glucose numbers with up to ten people, offering everyone a little more peace of mind.
Features that set Dexcom ONE+ apart from other CGM systems include multiple possibilities for personalization and flexibility. Dexcom CGM systems offer the most discretion, with three wear location options and are the only CGM systems to offer a ‘delay first high’ option, a customizable feature which allows a user to set a time before which their sensor will not alert them to a ‘high’ glucose reading, helping to avoid alert fatigue. Furthermore, designed to fit into a user’s life, Dexcom ONE+ also has the highest waterproof rating when compared to other CGM brands, allowing users to confidently continue using their device while showering or exercising.
Dexcom ONE+ is available today in Spain, Belgium and Poland, and will be available in the Netherlands next week. Additional countries in Europe, the Middle East and Africa will be announced in the following months.
